Publications by authors named "Tom Lung"

Claim this Profile
E
Evaluating the cost-effectiveness of levofloxacin therapy for household contacts of multidrug-resistant tuberculosis in Vietnam.
Tasnim Hasan, Nguyen Thu Anh, Nguyen Binh Hoa, Nguyen Viet Nhung, H Manisha Yapa, Tom Lung

Lancet Reg Health West Pac· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of a physiotherapist-led triage and treatment service on WAITing time for adults with musculoskeletal pain referred to Australian public hospital physiotherapy clinics: a protocol for the WAIT-less trial.
Joshua M Hutton, Andrew R Gamble, Chris G Maher, Tarcisio F de Campos, Christopher S Han, Tom Lung

BMJ Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes.
An Tran-Duy, Josh Knight, Andrew J Palmer, Dennis Petrie, Tom W C Lung

Diabetes Care· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication non-adherence in a cohort of chronically ill Australians: A case of missed opportunities.
Tracey-Lea Laba, Tom Lung, Stephen Jan, Anish Scaria, Tim Usherwood

Aust J Gen Pract· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the HUI3 and the EQ-5D-3L in a nursing home setting.
Tom Lung, Kirsten Howard, Christopher Etherton-Beer, Moira Sim, Gill Lewin

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease.
Blake Angell, Tracey-Lea Laba, Tom Lung, Alex Brown, Sandra Eades

Int J Equity Health· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making guidelines for economic evaluations relevant to public health in Australia.
Tom W Lung, Janani Muhunthan, Tracey-Lea Laba, Alan Shiell, Andrew Milat

Aust N Z J Public Health· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent trends in life expectancy for people with type 1 diabetes in Sweden.
Dennis Petrie, Tom W C Lung, Aidin Rawshani, Andrew J Palmer, Ann-Marie Svensson

Diabetologia· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality.
Tom W C Lung, Alison J Hayes, William H Herman, Lei Si, Andrew J Palmer

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
Rafael Perera, Emily McFadden, Julie McLellan, Tom Lung, Philip Clarke

Health Technol Assess· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden.
Tom W C Lung, Dennis Petrie, William H Herman, Andrew J Palmer, Ann-Marie Svensson

Diabetes Care· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of "healthy beginnings" an early childhood intervention to prevent obesity.
Alison Hayes, Tom Lung, Li Ming Wen, Louise Baur, Chris Rissel

Obesity (Silver Spring)· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness.
Andrew J Farmer, Richard Stevens, Jennifer Hirst, Tom Lung, Jason Oke

Health Technol Assess· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulating lifetime outcomes associated with complications for people with type 1 diabetes.
Tom W C Lung, Philip M Clarke, Alison J Hayes, Richard J Stevens, Andrew Farmer

Pharmacoeconomics· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation.
Tom W C Lung, Alison J Hayes, Andrew Hayen, Andrew Farmer, Philip M Clarke

Qual Life Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in bias in self-reported body mass index in Australia between 1995 and 2008 and the evaluation of correction equations.
Alison J Hayes, Philip M Clarke, Tom Wc Lung

Popul Health Metr· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis